Back to Search Start Over

Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey.

Authors :
Ellis SD
Vaidya R
Unger JM
Stratton K
Gills J
Van Veldhuizen P
Mederos E
Dressler EV
Hudson MF
Kamen C
Neuman HB
Kazak AE
Carlos RC
Weaver KE
Source :
Contemporary clinical trials communications [Contemp Clin Trials Commun] 2022 Aug 14; Vol. 29, pp. 100981. Date of Electronic Publication: 2022 Aug 14 (Print Publication: 2022).
Publication Year :
2022

Abstract

Purpose: Urological cancer clinical trials face accrual challenges, which may stem from structural barriers within cancer programs. We sought to describe the extent to which urology cancer care providers are available within community cancer research programs and explore the role of oncology practice group ownership in their access to urology practices to participate in research.<br />Materials and Methods: We conducted secondary analysis of organizational survey data collected in 2017 among National Cancer Institute Community Oncology Research Program practice groups. We used logistic regression to assess the association of self-reported access to urologists to participate in research and oncology practice group ownership type: independent, payor-provider, health-system, or public ownership.<br />Results: Of the 209 community oncology practice groups in the analysis sample, 133 (63.6%) had access to urologists for research participation. Ownership was not statistically significantly associated with access to urology practices after controlling for other covariates (p = 0.4). Instead, having a hospital outpatient clinic (p = 0.008) and identifying as a safety-net hospital (p = 0.035) were both positively significantly associated with access to urologists to participate in research.<br />Conclusions: Two-thirds of community cancer research groups have access to urology. Oncology ownership status was not associated with access to urologists for research. Research groups may need support to increase their capacity to engage non-oncology cancer care providers in research.<br /> (© 2022 Published by Elsevier Inc.)

Details

Language :
English
ISSN :
2451-8654
Volume :
29
Database :
MEDLINE
Journal :
Contemporary clinical trials communications
Publication Type :
Academic Journal
Accession number :
36033360
Full Text :
https://doi.org/10.1016/j.conctc.2022.100981